Dear Members,
The Board of Directors are delighted to present the 6th
Annual Report on the business and operations of HP Adhesives Limited ('the Company')
along with the summary of consolidated and standalone financial statements for the year
ended 31st March, 2025.
In compliance with the applicable provisions of the Companies Act,
2013, ('the Act'), the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), this
Board's Report is prepared based on the Standalone financial statements of the
Company for the year under review and also presents the key highlights of performance of
Subsidiary and its contribution to the overall performance of the Company for the year
under review.
OVERVIEW OF FINANCIAL PERFORMANCE
Key highlights of consolidated and standalone financial performance for
the year ended 31st March, 2025, are summarised as under:
(Rs in Lakhs)
Particulars |
Consolidated |
Standalone |
|
FY 2024-25 |
FY 2023-24 |
FY 2024-25 |
FY 2023-24 |
Revenue from operations |
25,287.16 |
23,590.60 |
25,124.64 |
23,590.60 |
Other income |
457.62 |
337.09 |
448.22 |
337.09 |
Total Revenue |
25,744.78 |
23,927.69 |
25,572.86 |
23,927.69 |
Total Expenditure |
23,371.94 |
21,138.44 |
23,254.36 |
21,138.44 |
Profit before Exceptional
items and tax |
2,372.84 |
2,789.26 |
2,318.50 |
2,789.26 |
Less: Exceptional items |
- |
22.40 |
- |
22.40 |
Profit Before Tax |
2,372.84 |
2,811.66 |
2,318.50 |
2,811.66 |
Tax expenses |
548.48 |
754.84 |
534.47 |
754.84 |
Profit after Tax |
1,824.36 |
2,056.81 |
1,784.03 |
2,056.81 |
Other Comprehensive Income for
the year |
(9.69) |
3.29 |
(9.69) |
3.29 |
Total Comprehensive Income for
the year |
1,814.67 |
2,060.10 |
1,774.34 |
2,060.10 |
FINANCIAL HIGHLIGHTS
Consolidated Performance
In FY 2024-25, Company reported Revenue from operations of 25287.16
Lakhs compared to 23,590.60 Lakhs in the previous financial year resulting in a growth of
7.19% year-on-year. Profit before tax (after exceptional items) decreased to 2,372.84
Lakhs in financial year ended March 2025 compared to Profit before tax (after exceptional
items) of 2,811.66 Lakhs in the previous year, a decline of 15.60%. Net Profit for the
year FY 2024-25 was Rs 1824.36 Lakhs compared to Rs 2056.81 Lakhs in the previous year FY
202324 registering a drop of 11.30%.
Revenue has increased due to healthy volume growth on account of
increasing distribution strength, deeper penetration in existing customers and addition of
new product categories. Though Profitability has got impacted in FY 2024-25, we believe
its not a structural decline but temporary in nature as the expenses have increased
primarily on account of increased employee expenses which are primarily in the sales team
which will lead to increased business in the coming years as well as higher initial costs
towards opening of new depots to serve its expanding distribution network and higher
business promotion expenses to maintain its market share in the industry as the demand
scenario was tepid in the year. Going forward, these investments are expected to yield
returns by way of increased revenue as well as improved profitability.
The financial results have been discussed in detail in the Management
Discussion and Analysis Report which forms part of this Annual report.
Standalone Performance
In FY 2024-25, Company reported Revenue from operations of 25124.64
Lakhs compared to 23,590.60 Lakhs in the previous financial year resulting in a growth of
6.50% year-on-year. Profit before tax (after exceptional items) decreased to 2,318.50
Lakhs in financial year ended March 2025 compared to Profit before tax (after exceptional
items) of 2,811.66 Lakhs in the previous year, a decline of 17.54%. Net Profit for the
year FY 2024-25 was Rs 1784.03 Lakhs compared to Rs 2056.81 Lakhs in the previous year FY
202324 registering a drop of 13.26%.
DIVIDEND & RESERVES Declaration and payment of dividend
The Board of Directors at their meeting held on 13th May,
2025, has recommended payment of Rs 0.40 (20%) per equity share of Rs 2/- each fully
paid-up as final dividend for the financial year 2024-25. The final dividend, subject to
the approval of the shareholders at the ensuing Annual General Meeting ("AGM")
of the Company.
In terms of Ind AS 10, events after the reporting period as notified by
the Ministry of Corporate Affairs, the proposed dividend of Rs 367.50 Lakhs is not
recognised as a liability as of 31st March, 2025.
The dividend, if approved at the ensuing AGM, would be paid to those
Members whose names appear in the Register of Members/Beneficial Owners maintained by the
depositories as stated in notice of the ensuing AGM.
Record date
The record date fixed for determining the entitlement of Members for
payment of dividend is Tuesday, 23rd September, 2025. According to the Finance
Act, 2020, dividend income will be taxable in the hands of the members and the Company is
required to deduct tax at source from the dividend paid to the members as per the rates
prescribed under Income Tax Act, 1961.
Unclaimed dividends
The provision of Section 125 of the Act is not applicable as the
Company has declared its first dividend in financial year 2023-24.
Transfer to Reserves
As permitted under the Act, the Board does not propose to transfer any
amount to general reserve and has decided to retain the entire amount of profit for FY
2024-25 in the retained earnings.
CHANGES IN THE NATURE OF BUSINESS
During the year under review, there has been no change in the nature of
business of the Company.
MATERIAL CHANGES AFFECTING THE COMPANY (AFTER CLOSURE OF FINANCIAL
YEAR)
There are no material changes and commitments, affecting the financial
position of the Company which has occurred between the close of the Financial Year as on
31st March, 2025, to which the Financial Statement relate and the date of this
Report.
SHARE CAPITAL
Authorised, Issued, Subscribed And Paid-Up Equity Share Capital
As on 31st March, 2025 the Authorised, Issued, Subscribed
and Paid-up Equity Share Capital of the Company is as follows:
| Particulars |
No. of Shares |
Face Value (Rs) |
Total Share Capital (in Rs) |
| Authorised |
10,00,00,000 |
2.00 |
20,00,00,000.00 |
| Issued, Subscribed and Paid-up |
9,18,74,735 |
2.00 |
18,37,49,470.00 |
Utilisation Of IPO Proceeds
Pursuant to Regulation 32 of the Listing Regulations, a
statement/explanation for the deviation(s) or variation(s) in the use of proceeds of IPO
is herein given below:
| Particulars of Issue |
Shares Issued |
Amount Raised |
Deviation(s) or Variation(s) in the use of
proceeds of issue, if any |
| IPO |
45,97,200 Equity Shares, out of which
41,40,000 Equity Shares were fresh issue and the balance 4,57,200 Equity Shares was an
offer for sale by Mrs. Anjana Haresh Motwani, Promoter of the Company. |
Out of the IPO Proceeds of Rs 12,596.33
Lakhs, proceeds to the Company through fresh issue of shares was Rs 11,343.60 Lakhs and
Net proceeds after IPO expenses was Rs 9,669.12 Lakhs. |
*There were no instances of deviation(s) or
variation(s) in the utilisation of proceeds as stated in the objects in Prospectus, in
respect of the IPO issue of the Company. |
*Necessary disclosures have been made to the Stock Exchanges in the
Statement of Deviation/Variation Report issued quarterly along with the Financial
Statements.
The proceeds of IPO were utilised for the objects as disclosed in the
Prospectus. Details as on 31st March, 2025 are as follows:
(' in Lakhs)
| Sr. No. |
Object |
Original Amount proposed to be utilised as
per the offer document |
Revised Amount proposed to be utilised |
Amount utilised* |
Amount Unutilised |
| 1. |
Funding capital expenditure for the Proposed
Expansion |
#2,550.86 |
2,550.86 |
2313.60 |
237.26 |
| 2. |
Funding the incremental working capital
requirements of our Company |
5,400.00 |
5,400.00 |
5,400.00 |
0.00 |
| 3. |
General corporate purposes |
1,723.50 |
1,718.20 |
1,718.20 |
0.00 |
|
Total |
9,674.36 |
9,669.06 |
9,431.80 |
237.26 |
*The amount utilised represents actual payments made inclusive of
taxes.
#The amount has been utilised for the Capex Object as defined in the
Prospectus. However, there has been a delay in utilisation of the Capex amount as compared
to revised timeline.
Details of delay in implementation of the object(s) are mentioned
hereunder:
| Object(s) |
Completion Date |
Delay (No. |
Comments of Board of Directors |
| Name |
As per Offer Document |
Actual |
of days/ months) |
Reason of delay |
Proposed Course of Action |
| Capex |
Q4 FY 2023-24 |
Q4 FY 202425 (balance payments by Q2 FY
2025-26) |
3-6 months from end of FY 2024-25, depending
upon delivery of machines / equipment / completion of contracts, etc. |
As there was a delay in spending in FY
2021-22 allocated amount, the amount proposed to be spent on capex in FY 2022-23 has
spilled over to FY 2023-24. However, capex for capacity additions have not been impacted
and the same has been carried out as per expected production forecast to meet estimated
demand. |
As mentioned in earlier Company Declarations,
unutilised IPO proceeds were to be utilised by Mar-25. Majority of capex IPO proceeds have
been utilised. Unutilised capex proceeds beyond 31 st March, 2025 is towards
those equipment's/machinery's/work orders where Purchase Orders / Work orders have been
issued before 31st March, 2025 (except one which is under negotiation) and only
balance payment is pending which is as per progress / delivery schedule. |
There has been no deviation in the utilisation of the IPO proceeds of
the Company. The Monitoring Agency Reports are available on the Company website
www.hpadhesives.com as well as submitted to stock exchanges.
DEPOSITS
During the year under review, the Company has not accepted any fixed
deposits within the meaning of Section 73 of the Act and the rules made there under.
HOLDING, SUBSIDIARIES, ASSOCIATE COMPANIES AND JOINT VENTURES
During the time under review, the Company formed one subsidiary -
Unitybond Solutions Private Limited; there are no Associate Companies or Joint Ventures.
Consolidated Financial Statements
According to Section 129(3) of the Act, the consolidated financial
statements of the Company and its Subsidiary is prepared in accordance with the relevant
Indian Accounting Standard specified under the Act, and the rules thereunder form part of
this Annual Report. A statement containing the salient features of the financial
statements of the Company's subsidiary in Form No. AOC-1 as "Annexure I" is
provided in this Annual Report.
Further, pursuant to the provisions of Section 136 of the Act, the
financial statements along with other relevant documents, in respect of subsidiaries, are
available on the Company's website at www.hpadhesives.com.
The details of the business of operating subsidiary during FY 2024-25
are given in the Management Discussion and Analysis Report, which forms part of this
Annual Report.
DIRECTORS AND KEY MANAGERIAL PERSONNEL
The constitution of the Board of the Company is in accordance with
Section 149(6) of the Act and Regulation 17 of the SEBI Listing Regulations. The detailed
composition of the Board as of 31st March, 2025 is as follows:
| Sr. No. |
Name of the Director |
Designation |
| 1 |
Mrs. Anjana Haresh Motwani |
Chairman & Executive Director |
| 2 |
Mr. Karan Haresh Motwani |
Managing Director |
| 3 |
Mrs. Nidhi Haresh Motwani |
Executive Director |
| 4 |
Mr. Surendra Kumar Mehta |
Independent Director |
| 5 |
Mr. Rajendra Kumar Jain |
Independent Director |
| 6 |
Mr. Ajeet Ananta Walavalkar |
Independent Director |
None of the Directors on the Board are disqualified under the
provisions of the Act.
In terms of the requirement of the SEBI Listing Regulations, the Board
has identified core skills, expertise, and competencies of the Directors in the context of
the Company's businesses for effective functioning. The list of key skills, expertise
and core competencies of the Board of Directors is detailed in the Corporate Governance
Report.
In the opinion of the Board, all the Directors, including the Directors
re-appointed during the year under review possess the requisite qualifications, experience
& expertise and hold high standards of integrity.
RETIREMENT BY ROTATION
Mrs. Anjana Motwani, Executive Director of the Company, is liable to
retire by rotation and being eligible for reappointment at the ensuing Annual General
Meeting ("AGM") of your Company, has offered herself for re-appointment. Her
details as required under the SEBI Listing Regulations are contained in the accompanying
Notice convening the ensuing AGM of your Company.
An appropriate resolution seeking your approval for her reappointment
as Director is included in the Notice.
INDEPENDENT DIRECTORS' DECLARATION
All the Independent Directors of the Company have submitted
declarations that each of them meets the criteria of independence as provided in Section
149(6) of the Act along with Rules framed thereunder and Regulation 16(1) (b) of SEBI
Listing Regulations and they continue to comply with the Code of Conduct laid down under
Schedule IV to the Act. In terms of Regulation 25(8) of SEBI Listing Regulations, the
Independent Directors have confirmed that they are not aware of any circumstance or
situation that exists or may be reasonably anticipated that could impair or impact their
ability to discharge their duties with an objective independent judgment and without any
external influence. The Directors have further confirmed that they are not debarred from
holding the office of the director under any SEBI Order or any other such authority.
In the opinion of the Board, there has been no change in the
circumstances which may affect their status as Independent Directors of the Company and
the Board is satisfied with the integrity, expertise, and experience (including
proficiency in terms of Section 150(1) of the Act and applicable rules thereunder) of all
Independent Directors on the Board. Further, in terms of Section 150 of the Act read with
Rule 6 of the Companies (Appointment and Qualification of Directors) Rules, 2014, as
amended, Independent Directors of the Company have included their names in the data bank
of Independent Directors and complied with the requirements of passing proficiency test,
as applicable.
KEY MANAGERIAL PERSONNEL
Mr. Karan Haresh Motwani, Managing Director, Mr. Mihir Suresh Shah,
Chief Financial Officer and Ms. Jyoti Nikunj Chawda, Company Secretary and Compliance
Officer are Key Managerial Personnel of the Company in accordance with the provisions of
Section(s) 2(51) and 203 of the Act read with the Companies (Appointment and Remuneration
of Managing Personnel) Rules, 2014. Further, Ms. Jyoti Nikunj Chawda, have resigned from
the post of Company Secretary & Compliance Officer w.e.f. 9th August, 2025.
BOARD AND COMMITTEE MEETINGS
The Board meetings are convened regularly to review and determine the
Company's business policies and strategies, alongside other key governance matters.
It maintains robust operational oversight with quarterly meetings featuring comprehensive
presentations. Board and Committee meetings are scheduled in advance and informed to
Directors, enabling them to plan their schedules effectively and participate meaningfully
in discussions. Only in case of special and urgent business matters, if the need arises,
Board's or Committee's approval is taken by passing resolutions through
circulation or by calling the Board / Committee meetings at a shorter notice, in
accordance with the applicable law.
The agenda for the Board and Committee meetings includes detailed notes
on the items to be discussed to enable the Directors to make an informed decision.
Your Board of Directors met 5 (Five) times during the FY 2024-25. The
details of the meetings and the attendance of the Directors are mentioned in the Corporate
Governance Report. The intervening gap between meetings were not more than 120 days as
required under the Act and SEBI Listing Regulations.
The Board of Directors of your Company have formed various committees,
as per the provisions of the Act and SEBI Listing Regulations and as a part of the best
corporate governance practises, the terms of reference and the constitution of these
Committees are in compliance with the applicable laws and to ensure focused attention on
business and for better governance and accountability. The constituted committees are as
below:
a) Audit Committee;
b) Nomination and Remuneration Committee;
c) Stakeholders Relationship Committee; and
d) Corporate Social Responsibility Committee.
The details with respect to the composition, terms of reference, number
of meetings held and business transacted by the aforesaid committees are given in the
Corporate Governance Report of the Company which is presented in a separate section and
forms a part of the Annual Report of the Company.
POLICY ON DIRECTORS' APPOINTMENT, REMUNERATION AND OTHER DETAILS
Based on the recommendation of the Nomination and Remuneration
Committee (NRC), the Board has adopted the Remuneration Policy for Directors, KMPs and
Senior Management Personnel. NRC has formulated the criteria for determining the
qualifications, positive attributes and independence of an Independent Director. The
Company's Policy on Directors' appointment and remuneration and other matters
provided in Section 178(3) of the Act is disclosed in the Corporate Governance Report,
which is a part of the Annual Report and is also available on
https://www.hpadhesives.com/wp-content/uploads/2014/08/Nomination-and-Remuneration-Policy.pdf.
BOARD EVALUATION AND ASSESSMENT
Pursuant to the provision of the Act read with Regulation 17 of the
SEBI Listing Regulations, the Board carried out a performance evaluation of the Board of
Directors as a whole, Committees of the Board and Individual Directors. The performance of
the Board as a whole, Committees and Individual Directors was evaluated by seeking inputs
from all Directors based on certain parameters as per the Guidance Note on Board
Evaluation issued by SEBI. The feedback received from the Directors was discussed and
reviewed by the Independent Directors at their separate annual meeting held on 12th
February, 2025, and also shared with the Board. The Independent Directors in the said
meeting also evaluated the quality, quantity and timeliness of the flow of information
between the Management and the Board, that is necessary for the Board to effectively and
reasonably perform their duties. They expressed their satisfaction in respect thereof.
FAMILIARISATION PROGRAMME
Towards familiarisation of the Independent Directors with the Company,
the independent directors of the Company were enlightened about the business affairs of
the Company, product portfolio, business strategies, financial performance and industry
scenario including those pertaining to Legislations & Economic environment and on
matters affecting the Company. Periodic presentations are also made at the Board and
Committee meetings on business and performance updates of the Company including Finance,
Sales, Marketing, Business strategy and risks involved.
The details of Familiarisation Program imparted to the Independent
Directors for the FY 2024-25 are available on the website of the Company at
www.hpadhesives.com.
DIRECTORS' RESPONSIBILITY STATEMENT
Pursuant to Section 134(5) of the Act, the Board of Directors, to the
best of their knowledge and ability, confirm that:
i. in preparation of the annual accounts for the year ended 31 st
March, 2025, the applicable accounting standards have been followed and there are no
material departures from the same;
ii. they have selected such accounting policies and applied them
consistently and made judgments and estimates that are reasonable and prudent so as to
give a true and fair view of state of affairs of the Company as at 31st March,
2025 and of the profit of the Company for the year ended on that day;
iii. they have taken proper and sufficient care for the maintenance of
adequate accounting records in accordance with the provisions of the Act for safeguarding
the assets of the Company and for preventing and detecting frauds and other
irregularities;
iv. the Annual Accounts for the year ended 31st March, 2025
have been prepared on a "going concern" basis;
v. they have laid down internal financial controls to be followed by
the Company and that such internal financial controls are adequate and were operating
effectively throughout the financial year ended 31st March, 2025; and
vi. they have devised proper systems to ensure compliance with the
provisions of all applicable laws and that such systems are adequate and operating
effectively throughout the financial year ended 31st March, 2025.
Further, there are no qualifications, reservations or adverse remarks
made by the statutory auditor/secretarial auditor in their respective reports.
BUSINESS RESPONSIBILITY REPORT
The provision of Regulation 34(2)(f) of the SEBI Listing Regulations,
regarding the Business Responsibility Report is not applicable to the Company.
MANAGEMENT DISCUSSION AND ANALYSIS REPORT
Pursuant to Regulation 34 of the SEBI Listing Regulations, a separate
section on Management Discussion and Analysis Report which also covers the consolidated
operations reflecting the global nature of our business forms an integral part of the
Integrated Annual Report.
CORPORATE GOVERNANCE REPORT
Pursuant to Regulation 34 read with Schedule V of the SEBI Listing
Regulations, a separate section on the Corporate Governance Report, forms an integral part
of the Annual Report. A certificate from Practicing Company Secretary confirming
compliance with corporate governance norms, as stipulated under the SEBI Listing
Regulations, is annexed to the Corporate Governance Report.
AUDITORS
Statutory Auditors:
Pursuant to the provisions of Section 139 of the Act, M/s. Priya
Choudhary & Associates LLP Chartered Accountant (Firm Registration No.
011506C/C400307) are appointed as the Statutory Auditor's of the Company from the
conclusion of 1st Annual General Meeting up to the conclusion of 6th Annual
General Meeting of the Company.
Further pursuant to the provisions of Section 139, 142 and other
applicable provisions, if any of the Companies Act, 2013 read with the Companies (Audit
and Auditors) Rules, 2014 (including any statutory modification(s) or re-enactment(s)
thereof for the time being in force) the Audit Committee and the Board of Directors have
approved the re-appointment and remuneration M/s. Priya Choudhary & Associates LLP,
Chartered Accountant (Firm Registration No. 01 1506C/ C400307) as the Statutory Auditors
of the Company, to hold office for a period of 5 (five) consecutive years commencing from
the conclusion of 6th Annual General Meeting till the conclusion of the 11th
Annual General Meeting of the Company to be held in the financial year 2030-31.
M/s. Priya Choudhary & Associates LLP has consented to act as the
Statutory Auditor of the Company and confirmed that their appointment, if approved, would
be within the limits prescribed under the Companies Act, 2013 and SEBI LODR Regulations.
They have further confirmed that they are not disqualified to be appointed as the
Statutory Auditor under the applicable provisions of the Act, rules made thereunder, and
SEBI Listing Regulations.
Secretarial Auditor:
Pursuant to the amended provisions of Regulation 24A of the SEBI
Listing Regulations and Section 204 of the Act, read with Rule 9 of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, the Audit Committee
and the Board of Directors have approved the appointment and remuneration of M/s. Shivam
Sharma & Associates, Practicing Company Secretaries (Certificate of Practice No.
16558), as the Secretarial Auditor of the Company for a term of five (5) consecutive
years, effective from 01st April, 2025 till March 31, 2030. The Board has
recommended his appointment for approval of the Members at the ensuing Annual General
Meeting (AGM).
A brief profile and other relevant details of M/s. Shivam Sharma &
Associates are provided in the Notice convening the ensuing AGM.
M/s. Shivam Sharma & Associates has consented to act as the
Secretarial Auditor of the Company and confirmed that their appointment, if approved,
would be within the limits prescribed under the Companies Act, 2013 and SEBI LODR
Regulations. They have further confirmed that they are not disqualified to be appointed as
the Secretarial Auditor under the applicable provisions of the Act, rules made thereunder,
and SEBI Listing Regulations.
AUDITOR'S REPORT
Statutory Audit Report:
The Auditor's Report on the financial statements of the Company
for the financial year ended 31st March, 2025 forms part of the Annual Report.
The said report was issued by the Statutory Auditor with an unmodified opinion and does
not contain any qualifications, reservations or adverse remarks. During the year under
review, the Auditors have not reported any fraud under Section 143(12) of the Act and
therefore disclosure of details under Section 134(3)(ca) of the Act is not applicable.
Secretarial Audit Report:
The Secretarial Audit Report in form MR-3 for FY 2024-25 is enclosed as
"Annexure II" to this report. The Secretarial Audit Report does not contain any
qualifications, reservations or adverse remarks. During the year under review, the
Secretarial Auditor has not reported any fraud under Section 143(12) of the Act and
therefore disclosure of details under Section 134(3)(ca) of the Act is not applicable.
ACCOUNTING TREATMENT
The accounting treatment is in line with the applicable Indian
Accounting Standards (IND-AS) as recommended by the Institute of Chartered Accountants of
India (ICAI) and prescribed by the Central Government.
SECRETARIAL STANDARDS
During the year under review, the Company has complied with all the
applicable provisions of Secretarial Standard - 1 and Secretarial Standard - 2 issued by
the Institute of Company Secretaries of India and notified by the Ministry of Corporate
Affairs.
CONTRACTS AND ARRANGEMENTS WITH RELATED PARTIES
Policy on Related Party Transactions and the same is available on its
website at
https://www.hpadhesives.com/wp-content/uploads/2025/05/Policy-on-Related-Party-Transaction-amended-on-12.02.2025.pdf.
The Policy captures framework for Related Party Transactions and
intends to ensure that proper reporting, approval and disclosure processes are in place
for all transactions with related parties.
All transactions with related parties are placed before the Audit
Committee for its review and approval. An omnibus approval from the Audit Committee is
obtained for the related party transactions which are repetitive in nature, based on the
criteria approved by the Audit Committee. The Audit Committee reviews all transactions
entered into pursuant to the omnibus approvals on a quarterly basis.
All transactions with related parties entered into during FY 2024-25
were at arm's length basis and in the ordinary course of business and in accordance
with the provisions of the Act and rules made thereunder, the SEBI Listing Regulations and
the Company's Policy on Related Party Transactions.
During the year under review, there were no transactions for which
consent of the Board was required to be taken in terms of Section 188(1) of the Act and
accordingly, no disclosure is required in respect of the related party transactions in
Form AOC-2 under Section 134(3)(h) of the Act and rules framed thereunder. Further, there
were no material related party transactions in terms of the SEBI Listing Regulations
requiring approval of the Members during the year under review. The attention of the
Members is drawn to note no. 30 of the financial statements setting out the disclosures on
related party transactions for FY 2024-25.
Pursuant to Regulation 23(9) of the SEBI Listing Regulations, your
Company has filed the reports on related party transactions with the Stock Exchanges
within statutory timelines.
CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE
EARNINGS AND OUTGO
The information on conservation of energy, technology absorption and
foreign exchange earnings and outgo stipulated under Section 134(3)(m) of the Act read
with Rule 8 of the Companies (Accounts) Rules, 2014, is enclosed as "Annexure
III" to this report.
RISK MANAGEMENT
The provision of Regulation 21(4) of SEBI Listing Regulations is not
applicable to the Company.
ANNUAL RETURN
Pursuant to Section 134(3)(a) of the Act, the Annual Return of the
Company prepared as per Section 92(3) of the Act for the financial year ended 31st
March, 2025, is available on the Company's website and can be accessed at
www.hpadhesives.com. In terms of Rules 11 and 12 of the Companies (Management and
Administration) Rules, 2014, the Annual Return shall be filed with the Registrar of
Companies, within prescribed timelines.
SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS
During the year under review, there were no significant and material
orders passed by the Regulators / Courts that would impact the going concern status of the
Company and its future operations.
DETAILS OF APPLICATION MADE OR ANY PROCEEDING PENDING UNDER THE
INSOLVENCY AND BANKRUPTCY CODE, 2016 DURING THE YEAR ALONG WITH THEIR STATUS AS AT THE END
OF THE FINANCIAL YEAR
During the year under review and till date of this Report, the Company
has neither made any application against anyone nor any proceedings were pending against
the Company under the Insolvency and Bankruptcy Code, 2016.
CORPORATE SOCIAL RESPONSIBILITY (CSR)
In compliance with the provisions of Section 135 of the Act read with
the Companies (Corporate Social Responsibility Policy) Rules, 2014, the Company has
constituted a Corporate Social Responsibility (CSR) Committee. It is committed to ensure
the social well-being of the communities through its CSR initiatives, in alignment with
the Company's key priorities. The details of the Committee along with its terms of
reference have been provided in the Corporate Governance Report.
The Company has adopted a Corporate Social Responsibility Policy in
accordance with the Companies (Corporate Social Responsibility Policy) Rules, 2014 which
can be accessed at
https://www.hpadhesives.com/wp-content/uploads/2014/08/Corporate-Social-Responsibility-Policy.pdf.
The brief outline of the CSR Policy of the Company and the initiatives
undertaken by the Company during the financial year ended 31st March, 2025, in
accordance with Section 135 of the Act and Companies (Corporate Social Responsibility
Policy) Rules, 2014 is set out in "Annexure IV" to this report.
INTERNAL FINANCIAL CONTROL
The Company has laid down internal financial control through entity
level control inter-alia to ensure orderly and efficient conduct of business, including
adherence to the Company's policies and procedures, accuracy and completeness of
accounting records and timely preparation and reporting of reliable financial
statements/information, safeguarding of assets, prevention and detection of frauds and
errors.
The Board of Directors of the Company have adopted various policies
like Related Party Transactions Policy, Whistle Blower Policy, Code of Conduct for
regulating, monitoring and reporting Insider Trading and such other procedures for
ensuring the orderly and efficient conduct of its business, prevention and detection of
frauds and errors, accuracy and completeness of the accounting and timely preparation of
financial information.
Based on the requirements under SEBI (Prohibition of Insider Trading)
Regulations, 2015, the Board has approved the Code of Conduct for Prohibition of Insider
Trading and the same is being implemented by the Company.
VIGIL MECHANISM
In pursuance of the provisions of Section 177(9) & (10) of the Act
and Regulation 22 of SEBI Listing Regulations, a vigil mechanism named "HP Adhesives
Limited Whistle Blower
Policy" for Directors and employees to report genuine concerns has
been established. The policy on whistle mechanism can be accessed at
https://www.hpadhesives.
com/wp-content/uploads/2014/08/Vigil-Mechanism-Whistle-Blower-Policy.pdf.
The policy lays down a framework and process, which provides a platform
to disclose information, confidentially and without fear of reprisal or victimisation,
where there is reason to believe that there has been serious malpractice, fraud,
impropriety, abuse or wrongdoing, grievances about leakage of unpublished price sensitive
information, illegal and unethical behaviour within the Company to the Vigilance Officer.
PARTICULARS OF LOANS, GUARANTEES AND INVESTMENTS
During the period under review, the Company has not provided any loans/
investments which come under the provisions of Section 186 of the Companies Act, 2013.
SHARE REGISTRAR & TRANSFER AGENT (R&T)
Bigshare Services Private Limited is the Registrar and Transfer Agent
of the Company. They were appointed as the Registrar and Share Transfer Agent of the
Company with effect from 07th July, 2021.
PREVENTION OF SEXUAL HARASSMENT OF WOMEN AT WORKPLACE POLICY
The Company has zero tolerance for sexual harassment at the workplace
and has adopted a policy on prevention, prohibition and redressal of sexual harassment at
workplace in line with the provisions of Sexual Harassment of Women at Workplace
(Prevention, Prohibition and Redressal) Act, 2013 and the rules framed thereunder. The
Company has duly constituted an Internal Complaints Committee (ICC) as required under
Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013.
During the year under review, no complaint pertaining to sexual harassment at work place
has been received by the Company.
PARTICULARS OF EMPLOYEES AND RELATED DISCLOSURES
The information required under Section 197(12) of the Act read with
Rule 5 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014
(including amendments thereto), is attached as "Annexure V" to this Report.
EMPLOYEES STOCK OPTION SCHEME
The Company has adopted the HP ADHESIVES EMPLOYEES STOCK OPTION SCHEME
- 2024 (the "ESOP 2024 Scheme") for a pool of 15,00,000 options. Further, the
Company has not made any grants under the ESOP 2024 Scheme. A certificate pursuant to
Regulation 13 of the Securities and Exchange Board of India (Share Based Employee Benefits
and Sweat Equity) Regulations, 2021 has been obtained from Shivam Sharma & Associates,
Secretarial Auditors of the Company, and is annexed to this Report
HUMAN RESOURCES
The Company considers its Human Resource (HR) as the key to achieve its
objectives. HR and Functional Department creates all strategies along with Senior
Management and Board of Directors to attract talent and build capabilities. The employees
are sufficiently empowered and enabled to work in an environment that inspires them to
achieve higher levels of performance. The unflinching commitment of the employees is the
driving force behind fulfilling the Company's vision. Your Company appreciates the
contribution of its dedicated employees.
COMPLIANCE WITH THE MATERNITY BENEFIT ACT, 1961
The Company has complied with the provisions of the Maternity Benefit
Act, 1961, including all applicable amendments and rules framed thereunder. The Company is
committed to ensuring a safe, inclusive, and supportive workplace for women employees. All
eligible women employees are provided with maternity benefits as prescribed under the
Maternity Benefit Act, 1961, including paid maternity leave, nursing breaks, and
protection from dismissal during maternity leave.
GENERAL
Your directors state that no disclosure or reporting is required in
respect of following items as there were no transactions on these items during the year
under review:
a. Issue of equity shares with differential voting rights as to
dividend, voting or otherwise;
b. Issue of shares (including sweat equity shares) to employees of the
Company under any scheme;
c. No significant or material orders passed by the Regulators or Courts
or Tribunals which impact the going concern status and Company's operations in
future;
d. No frauds were reported by the Auditors during the year under
review; and
e. Maintenance of Cost Records as specified by the Central Government
under Section 148(1) of the Companies Act, 2013 is not required by the Company.
CAUTIONARY STATEMENT
Statements in the Board's Report and the Management Discussion
& Analysis Report describing the Company's objectives, expectations or forecasts
may be forward-looking within the meaning of applicable laws and regulations. Actual
results may differ from those expressed in the statements.
ACKNOWLEDGEMENTS
Your Directors express their gratitude to the members, bankers,
customers, regulatory and statutory authorities, and other business stakeholders for their
valuable support and co-operation.
Your directors also thank the employees of the Company for their
continued contribution, commitment and dedication.